WCM
EPZM

Weld Capital Management’s Epizyme, Inc EPZM Stock Holding History

Weld Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30,301
Closed -$745K – 788
2019
Q4 		$745K Buy
+30,301
New +$450K 0.14% 247
2019
Q2 		– Sell
-49,910
Closed -$618K – 993
2019
Q1 		$618K Buy
+49,910
New +$558K 0.11% 333

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Weld Capital Management's EPZM Position: Q1 2020 in Review

Weld Capital Management sold out of Epizyme, Inc (EPZM) in Q1 2020, closing a stake of 30,301 shares — an estimated $745K sold.

Weld Capital Management first reported a position in EPZM in Q1 2019 and held it in 2 quarters. The position peaked at $745K in Q4 2019. 143 funds tracked by Wall St. Rank hold EPZM as of Q1 2020.

  • Weld Capital Management reported no remaining Epizyme, Inc position as of Q1 2020 after selling out during the quarter.
  • Weld Capital Management sold 30,301 Epizyme, Inc shares in Q1 2020, an estimated $745K.
  • Weld Capital Management first reported a position in Epizyme, Inc in Q1 2019 and held it in 2 quarters.
  • Weld Capital Management's Epizyme, Inc position peaked at $745K in Q4 2019.
  • 143 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2020.

Based on Weld Capital Management's 13F filing for Q1 2020, filed 15 May 2020.